Creative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs has established a broad range of platforms for developing novel antibodies or equivalents. These cutting-edge technologies enable our scientists to meet your demands from different aspects and tailor the most appropriate solution that contributes to the success of your projects.
HighlightsWith deep understanding in antibody-related realms and extensive project experience, Creative Biolabs offers a variety of references to help you learn more about our capacities and achievements, including infographic, flyer, case study, peer-reviewed publications, and all kinds of knowledge that can assist your projects. You are also welcome to contact us directly for more specific solutions.
HighlightsGet a real taste of Creative Biolabs, one of the most professional custom service providers in the world. We are committed to providing highly customized comprehensive solutions with the best quality to advance your projects.
Highlights
Are you struggling to find the perfect binder for your research? Whether it’s antibodies, peptides, or small molecules, Creative Biolabs offers a range of advanced discovery services to identify the ideal binders tailored to your specific needs. Let us help you unlock the potential of your next breakthrough.
Request a Quote
Comprehensive technology platforms for precise binder discovery
We utilize state-of-the-art technologies to provide the most accurate binder discovery, ensuring you get the perfect match for your research goals.
Our broad selection of platforms, including Phage, Yeast, and Mammalian Display, allows us to address a wide range of targets and applications.
Every project is unique. Our flexible approach means we tailor each discovery process to meet your specific needs, ensuring optimal results.
With rapid turnaround times and high-quality data, we ensure your project stays on schedule and meets your expectations.
A streamlined process for efficient binder identification
Every project begins with a consultation to discuss your goals, targets, and the specific requirements for the binder discovery process.
Our scientists deploy advanced technologies to screen a variety of binders through proven techniques like Phage Display, Yeast Display, and more.
Once we’ve identified potential binders, we conduct in-depth analysis, assessing binding affinity, specificity, and stability to ensure the best candidates.
You’ll receive a comprehensive report with all findings, including raw data and detailed insights to help you make informed decisions.
Technology-specific solutions for diverse binder discovery needs
Our phage display-based binder discovery service utilizes large libraries of peptides or antibodies displayed on the surface of bacteriophages to screen for optimal binders. This highly efficient method is perfect for identifying binders against a wide range of targets, including those difficult to characterize.
Our yeast display technology offers a robust and versatile platform for screening high-affinity binders. Yeast cells are used to display peptides or antibodies on their surface, allowing for the discovery of specific binders to both soluble and membrane-bound targets.
We provide access to an extensive collection of pre-constructed peptide and antibody libraries, which can be screened for potential binders to your target. This service is ideal for clients who want to expedite the discovery process with a ready-to-use library.
Our Native™ antibody discovery service allows us to isolate rare B cells that produce the antibodies specific to your target. This service eliminates the need for hybridoma technology and is much faster, directly providing high-quality antibodies for research or therapeutics.
Hybridoma technology remains one of the most reliable methods for producing monoclonal antibodies. We combine this traditional technology with advanced screening to create antibodies with high specificity, perfect for research.
With our Magic™ platform, we use transgenic mice to produce fully human antibodies with high affinity and specificity. This service is ideal for developing antibodies for your preclinical study.
Our biomolecular interaction-based discovery service allows you to explore protein-protein, protein-DNA, and protein-small molecule interactions. We use cutting-edge technologies to uncover potential binders, providing valuable insights for target validation and drug discovery.
Using bacterial cells to display peptides or antibodies on their surface, we can rapidly screen for binders to your target. This method is quick, efficient, and scalable for a variety of targets, making it an ideal solution for early-stage discovery.
Our ribosome display service allows us to link peptides with their encoding mRNA, creating a powerful tool for high-throughput screening. This method is especially effective for finding peptides or small molecules that bind specifically to your target.
Mammalian display technology is perfect for discovering binders against complex, membrane-bound targets such as GPCRs or ion channels. This platform ensures that we can find high-affinity binders that interact with native-like antigens.
DNA immunization is a revolutionary approach to creating high-affinity antibodies without the use of traditional animal models. We use DNA encoding target antigens to stimulate the immune system, accelerating the discovery of novel binders.
State-of-the-art tools for precise and efficient binder identification
We use phage display technology to screen vast peptide or antibody libraries, ensuring the identification of high-affinity binders with exceptional specificity.
Explore Phage Display →
Our yeast display system is designed to efficiently screen binders to both soluble and membrane-bound targets, leveraging yeast cells for natural protein folding.
Explore Yeast Display →
Ribosome display allows for the high-throughput screening of peptides by linking them with their encoding mRNA, enabling efficient discovery of specific binders.
Explore Ribosome Display →
With Native™ Antibody Discovery, we quickly isolate B cells producing target-specific antibodies, bypassing traditional hybridoma limitations for faster results.
Explore B Cell Sorting →
Get the big picture of our multi-platform screening strategies—phage, yeast, ribosome, and more—all in one visual guide.
Download NowWe can work with a variety of sample types, including purified proteins, cell lines, and even serum. Whether you're working with a peptide or antibody, we'll tailor the discovery process to your specific sample type.
Absolutely! Yeast Display is perfect for complex targets like membrane proteins and glycoproteins. We can address even the most challenging targets with our tailored approach, ensuring optimal binder identification.
While most projects take about 6-8 weeks, we understand the need for speed. For time-sensitive projects, we can often expedite the process to meet your deadlines without compromising on quality.
Our final report includes detailed binding affinity analysis (KD, Ka, Kd), epitope classification, and off-target identification. We provide you with both raw data and comprehensive insights to guide your next steps.
Definitely. That’s what our scientific consultation is for! We’ll evaluate your target type, project goals, and timeline, then recommend the most appropriate platform—be it Phage Display, Yeast Display, or Native™ B Cell Sorting. Each has unique strengths, and our job is to match the right tool to your research.
It depends on the platform. If you already have expression constructs, great! But if not, we can help design and synthesize them based on your target sequence. Just let us know what stage you're at—we're flexible.
All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.
